We perform YB-1 immunohistochemical staining using tumor tissues in the xenograft models, and find that YB-1 is significantly reduced in the tumor cells with downregulated MIR200CHG expression (Fig. 6a). This evidence concerns the gene YBX1 and neoplasm.